1. Inferring the initiation and development of myeloproliferative neoplasms.
- Author
-
Hermange G, Rakotonirainy A, Bentriou M, Tisserand A, El-Khoury M, Girodon F, Marzac C, Vainchenker W, Plo I, and Cournède PH
- Subjects
- Bayes Theorem, Humans, Models, Biological, Mutation, Calreticulin genetics, Janus Kinase 2 genetics, Myeloproliferative Disorders genetics
- Abstract
The developmental history of blood cancer begins with mutation acquisition and the resulting malignant clone expansion. The two most prevalent driver mutations found in myeloproliferative neoplasms- JAK2
V617F and CALRm -occur in hematopoietic stem cells, which are highly complex to observe in vivo. To circumvent this difficulty, we propose a method relying on mathematical modeling and statistical inference to determine disease initiation and dynamics. Our findings suggest that CALRm mutations tend to occur later in life than JAK2V617F . Our results confirm the higher proliferative advantage of the CALRm malignant clone compared to JAK2V617F . Furthermore, we illustrate how mathematical modeling and Bayesian inference can be used for setting up early screening strategies.- Published
- 2022
- Full Text
- View/download PDF